Myeloma ECOG 3A0G

March 13, 2013

Location: The Hospital of Central Connecticut

Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic HighRisk Smoldering Multiple Myeloma.

Connect With Us

Subscribe to Our Newsletters

Get the latest healthcare news directly in your inbox.

Hartford HealthCare Offices

One State Street, Suite 19, Hartford, CT 06103 • Contact Us

Donations to Hartford HealthCare are managed by the Hartford Hospital Department of Philanthropy, a Connecticut tax-exempt organization under section 501(c)(3) of the IRS code (E.I.N. 06-0646668). For more information, click here.

Interpretive Services

Community Health Needs Assessment
Financial Assistance
Non-Discrimination
Patient Rights & Privacy
Website Terms & Conditions
Website Privacy Policy

Design by Julia Balfour, LLC

Alert: Click to view COVID-19 testing site information >>

Alert: The COVID-19 vaccine is now available to everyone age 16+ >>

Alert: Click to view coronavirus general information >>

Alert: Información sobre coronavirus en Español >>

Myeloma ECOG 3A0G

Connect With Us

Subscribe to Our Newsletters

Hartford HealthCare Offices

Alert: The COVID-19 vaccine is now available to everyone age 16+ >>

Alert: Click to view coronavirus general information >>

Alert: Información sobre coronavirus en Español >>

By Region:

Myeloma ECOG 3A0G

Connect With Us

Subscribe to Our Newsletters

Hartford HealthCare Offices